Merriman Curhan Ford initiates coverage on Helix Biopharma Cp (OTC: HXBPF) with a Buy rating.

The firm notes, Helix ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE